高级检索
当前位置: 首页 > 详情页

PLGA-Based Drug Delivery Systems for Remotely Triggered Cancer Therapeutic and Diagnostic Applications.

文献详情

资源类型:
Pubmed体系:

收录情况: ◇ EI

机构: [1]Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu, China [2]School of Life Sciences and Technology, University of Electronic Science and Technology of China, Chengdu, China [3]Center for Information in Biology, University of Electronic Science and Technology of China, Chengdu, China [4]Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
出处:
ISSN:

关键词: PLGA-based DDSs targeting remotely triggered cancer therapy imaging theranostics

摘要:
Intelligent drug delivery systems based on nanotechnology have been widely developed and investigated in the field of nanomedicine since they were able to maximize the therapeutic efficacy and minimize the undesirable adverse effects. Among a variety of organic or inorganic nanomaterials available to fabricate drug delivery systems (DDSs) for cancer therapy and diagnosis, poly(D,L-lactic-co-glycolic acid) (PLGA) has been extensively employed due to its biocompatibility and biodegradability. In this paper, we review the recent status of research on the application of PLGA-based drug delivery systems (DDSs) in remotely triggered cancer therapy and the strategies for tumor imaging provided by PLGA-based DDSs. We firstly discuss the employment of PLGA-based DDSs for remotely triggered cancer therapy, including photo-triggered, ultrasound-triggered, magnetic field-triggered, and radiofrequency-triggered cancer therapy. Photo-triggered cancer therapy involves photodynamic therapy (PDT), photothermal therapy (PTT), and photo-triggered chemotherapeutics release. Ultrasound-triggered cancer therapy involves high intensity focused ultrasound (HIFU) treatment, ultrasound-triggered chemotherapeutics release, and ultrasound-enhanced efficiency of gene transfection. The strategies which endows PLGA-based DDSs with imaging properties and the PLGA-based cancer theranostics are further discussed. Additionally, we also discuss the targeting strategies which provide PLGA-based DDSs with passive, active or magnetic tumor-targeting abilities. Numerous studies cited in our review demonstrate the great potential of PLGA-based DDSs as effective theranostic agent for cancer therapy and diagnosis. Copyright © 2020 Shen, Li, Xie, Feng, Chen, Yang, Wu, Deng and Liu.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 工程技术
小类 | 3 区 综合性期刊
最新[2023]版:
大类 | 3 区 工程技术
小类 | 3 区 综合性期刊
第一作者:
第一作者机构: [1]Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu, China
通讯作者:
通讯机构: [2]School of Life Sciences and Technology, University of Electronic Science and Technology of China, Chengdu, China [4]Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号